Effects of desflurane, sevoflurane and halothane on postinfarction spontaneous dysrhythmias in dogs

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 3, 1998, Pages 353-357

  Novalija, E ^a   Hogan, Q H ^a   Kulier, A H ^a   Turner, L H ^a   Bosnjak, Z J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Anesthetics; Complications; Desflurane; Halothane; Myocardial infarction; Sevoflurane; Ventricul ar dysrhythmia; Volatile

Indexed keywords

BEUTHANASIA; BUPRENORPHINE; DESFLURANE; HALOTHANE; SEVOFLURANE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOG; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031889430     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb04929.x     Document Type: Article

References (30)

1. Hurwitz JL, Josephson ME. Sudden cardiac death in patients with chronic coronary heart disease. Circulation 1992: 85 (suppl 1): 43-49.
2. Janse MJ, Witt AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989: 69: 1049-1169.
3. Josephson ME. Clinical cardiac electrophysiology. Philadelphia: Lea & Febiger, 1993.
4. Kastor J. Arrhythmias. Philadelphia: WB Saunders, 1994.
5. Witt AL, Janse MJ. The ventricular arrhythmias of ischemia and infarction. Mount Kisco, NY: Futura, 1993.
6. Atlee JL. Halothane: cause or cure for arrhythmias? [editorial] Anesthesiology 1987: 67: 617-618.
7. Atlee JL, Bosnjak ZJ. Mechanisms for cardiac dysrhythmias during anesthesia. Anesthesiology 1990: 72: 889-901.
8. Dennis AR, Richards DA, Taylor AT et al. Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction. Bas Res Cardiol 1989: 84: 5-12.
9. Hunt GB, Ross DL. Comparison of effects of three anesthetic agents on induction of ventricular tachycardia in a canine model of myocardial infarction. Circulation 1988: 78: 221-226.
10. Deutsch N, Hantler CB, Tait AR et al. Suppression of ventricular arrhythmias by volatile anesthetics in a canine model of chronic myocardial infarction. Anesthesiology 1990: 72: 1012-1102.
11. Gallagher JD, McClernan CA. The effects of halothane on ventricular tachycardia in intact dogs. Anesthesiology 1991: 75: 866-875.
12. Kroll DA, Knight PR. Antifibrilatory effects of volatile anesthetics in acute occlusion/reperfusion arrhythmias. Anesthesiology 1984: 61: 657-661.
13. Turner LA, Polic S, Hoffman R et al. Actions of volatile anesthetics on ischemic and nonischemic Purkinje fibers in the infarcted canine hearts: Regional action potential characteristics. Anesth Analg 1993: 76: 726-733.
14. Turner LA, Bosnjak ZJ, Kampine JP. Actions of halothane on the electrical activity of Purkinje fibers derived from normal and infarcted canine hearts. Anesthesiology 1987: 67: 612-629.
15. Eger EI II. Partition coefficients of I-653 in human blood, saline, and olive oil. Anesth Analg 1987: 66: 971-973.
16. Strum D, Eger EI II. Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg 1987: 66: 654-656.
17. Eger R, Eger EI II. Effect of temperature and age on solubility of enflurane, halothane, isoflurane and methoxyflurane in human blood. Anesth Analg 1985: 64: 640-642.
18. Yasuda N, Targ A, Eger EI II. Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 1989: 69: 370-373.
19. Hayashi Y, Sumikawa K, Tashiro C et al. Arrhythmogenic threshold of epinephrine during sevoflurane, enflurane and isoflurane anesthesia in dogs [letter]. Anesthesiology 1988: 69: 145-147.
20. Moore M, Weiskopf R, Eger EI II, Wilson C. Arrhythmogenic doses of epinephrine are similar during desflurane or isoflurane anesthesia in humans. Anesthesiology 1993: 79: 943-947.
21. Guide for the Care and Use of Laboratory Animals. DHEW Publication No. (NIH) 85-23. Revised 1985. Bethesda, MD: Office of Science and Health Reports DRR/NIH.
22. Woehlck HJ, Vicenzi MN, Bosnjak ZJ et al. Anesthetics and automaticity of dominant and latent pacemakers in chronically instrumented dogs. I. Methodology, conscious state, and halothane anesthesia - comparison with and without muscarinic blockade during exposure to epinephrine. Anesthesiology 1993: 79: 1304-1315.
23. Harris AS. Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1950: 1: 1318-1321.
24. Doorley BM, Waters SJ, Terrell RC, Robinson JL. MAC of I-653 in beagle dogs and New Zealand white rabbits. Anesthesiology 1988: 69: 89-91.
25. Kazama T, Kazuyuki I. Comparison of MAC and rate of rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog. Anesthesiology 1988: 64: 435-437.
26. Eger EI II, Johnson B. Rates of awakening from anesthesia with I-653, halothane, isoflurane, and sevoflurane: A test of the effect of anesthetic concentration and duration in rats. Anesth Analg 1987: 66: 977-982.
27. Ebert TJ, Muzi M. Sympathetic activation with desflurane in humans. Adv Pharmacol 1994: 31: 369-378.
28. Laszlo A, Polic S, Kampine JP et al. Halothane, enflurane and isoflurane on abnormal automaticity and triggered rhythmic activity of Purkinje fibers from 24-hour-old infarcted canine hearts. Anesthesiology 1991: 75: 847-853.
29. Atlee JL. Arrhythmias and pacemakers. Philadelphia: WB Saunders, 1996.
30. Patterson E, Gibson J, Lucchesi B. The electrophysiologic effects of disopyramide phosphate upon reentrant ventricular arrhythmias in conscious dogs after myocardial infarction. Am J Cardiol 1980: 46: 792-799.